Even in the 309 meningiomas with chromosome 22 loss, these canonical non-NF2 mutations were mutually exclusive with NF2 mutations (p = 0.02), suggesting that loss of chromosome 22 may not be driving bi-allelic inactivation of NF2 in tumors with non-NF2 driver alterations. This evidence concerns the gene NF2 and meningioma.